Summit Asset Management, LLC Pfizer Inc Transaction History

Summit Asset Management, LLC

$841 Million
Q1 2024

A detailed history of Summit Asset Management, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Summit Asset Management, LLC holds 21,939 shares of PFE stock, worth $615,388. This represents 0.07% of its overall portfolio holdings.

Number of Shares

21,939

Previous 21,963 0.11%

Holding current value

$615,388

Previous $632,000 3.8%

% of portfolio

0.07%

Previous 0.09%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	SELL	$25.89 - $29.73 $621 - $713	-24 Reduced 0.11%	21,939 $608,000
Q4 2023 Feb 06, 2024	SELL	$26.13 - $33.94 $4,834 - $6,278	-185 Reduced 0.84%	21,963 $632,000
Q3 2023 Nov 06, 2023	BUY	$32.09 - $37.51 $4,845 - $5,664	151 Added 0.69%	22,148 $734,000
Q2 2023 Aug 07, 2023	SELL	$36.12 - $41.79 $11,197 - $12,954	-310 Reduced 1.39%	21,997 $806,000
Q1 2023 May 11, 2023	BUY	$39.39 - $51.28 $5,553 - $7,230	141 Added 0.64%	22,307 $910,000

Q4 2022 Feb 13, 2023	SELL	$41.75 - $54.5 $208 - $272	-5 Reduced 0.02%	22,166 $1.14 Million
Q3 2022 Nov 07, 2022	SELL	$43.76 - $53.42 $118,020 - $144,073	-2,697 Reduced 10.85%	22,171 $970,000
Q2 2022 Aug 10, 2022	SELL	$46.53 - $55.17 $16,052 - $19,033	-345 Reduced 1.37%	24,868 $1.3 Million
Q1 2022 May 09, 2022	BUY	$45.75 - $56.69 $40,031 - $49,603	875 Added 3.6%	25,213 $1.31 Million
Q4 2021 Feb 11, 2022	BUY	$41.32 - $61.25 $65,905 - $97,693	1,595 Added 7.01%	24,338 $1.44 Million
Q3 2021 Nov 08, 2021	BUY	$39.25 - $50.42 $17,937 - $23,041	457 Added 2.05%	22,743 $978,000
Q2 2021 Aug 06, 2021	BUY	$35.91 - $40.68 $39,249 - $44,463	1,093 Added 5.16%	22,286 $873,000
Q1 2021 May 07, 2021	SELL	$33.49 - $37.77 $2,645 - $2,983	-79 Reduced 0.37%	21,193 $768,000
Q4 2020 Feb 09, 2021	BUY	$33.47 - $42.56 $736 - $936	22 Added 0.1%	21,272 $783,000
Q3 2020 Nov 06, 2020	BUY	$31.75 - $37.25 $17,875 - $20,971	563 Added 2.72%	21,250 $780,000
Q2 2020 Aug 07, 2020	BUY	$30.12 - $36.54 $11,415 - $13,848	379 Added 1.87%	20,687 $676,000
Q1 2020 May 08, 2020	BUY	$27.03 - $38.62 $27,705 - $39,585	1,025 Added 5.32%	20,308 $663,000
Q4 2019 Feb 07, 2020	SELL	$32.92 - $37.36 $20,640 - $23,424	-627 Reduced 3.15%	19,283 $756,000
Q3 2019 Nov 06, 2019	BUY	$32.49 - $42.13 $1,592 - $2,064	49 Added 0.25%	19,910 $715,000
Q2 2019 Aug 07, 2019	BUY	$36.98 - $41.52 $2,625 - $2,947	71 Added 0.36%	19,861 $860,000
Q1 2019 May 07, 2019	SELL	$37.5 - $41.2 $42,562 - $46,762	-1,135 Reduced 5.42%	19,790 $840,000
Q4 2018 Feb 07, 2019	BUY	$38.47 - $43.86 $8,040 - $9,166	209 Added 1.01%	20,925 $913,000
Q3 2018 Nov 06, 2018	BUY	$34.47 - $41.81 $35,779 - $43,398	1,038 Added 5.27%	20,716 $913,000
Q2 2018 Aug 07, 2018	SELL	$32.98 - $35.16 $329 - $351	-10 Reduced 0.05%	19,678 $714,000
Q1 2018 May 07, 2018	SELL	$31.91 - $37.02 $3,063 - $3,553	-96 Reduced 0.49%	19,688 $699,000
Q4 2017 Feb 06, 2018	SELL	$33.26 - $35.29 $2,394 - $2,540	-72 Reduced 0.36%	19,784 $717,000
Q3 2017 Nov 09, 2017	BUY	$31.0 - $34.15 $615,536 - $678,082	19,856	19,856 $709,000

Others Institutions Holding PFE

# of Institutions

3,158

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit Asset Management, LLC with notifications on news.

Account

Summit Asset Management, LLC Pfizer Inc Transaction History